A Multi-Center, Low-Interventional Study With a Retrospective Component in Participants With Late-Onset Pompe Disease
Latest Information Update: 14 Mar 2024
Price :
$35 *
At a glance
- Drugs SPK 3006 (Primary)
- Indications Glycogen storage disease type II
- Focus Pharmacodynamics
- Sponsors Spark Therapeutics
- 14 Jul 2021 Status changed from recruiting to completed.
- 25 Aug 2020 Status changed from active, no longer recruiting to recruiting.
- 14 May 2020 Status changed from recruiting to active, no longer recruiting.